Pasar al contenido principal

Refine your results

Filtros
Buscar
Include spaces in matter number if applicable. Ex.: 182 3125
Fecha
Displaying 6141 - 6160 of 18372
Early Termination Notices

20130594: Praxair, Inc.; Aurora Equity Partners III L.P.

… 20130594: Praxair, Inc.; Aurora Equity Partners III L.P. HSR Early Termination Notice 20130594: Praxair, Inc.; Aurora Equity Partners III L.P. 20130594 NuCO2, Inc. Aurora Equity Partners III L.P. Praxair, Inc. … 20130594: Praxair, Inc.; Aurora Equity …
Date
Acquiring Party
Praxair, Inc.
Acquired Party
Aurora Equity Partners III L.P.
Acquired Entities
NuCO2, Inc.
HSR Informal Interpretations

1302005 Informal Interpretation

… 1302005 Informal Interpretation 1302005 Informal Interpretation From: (Redacted) Sent: Wednesday, February 13, … financing transactions. In these transactions, investors provide an upfrontcash amount to green energy projects(such …
Date
Rule
801.21, 802.4
corporate entity would be exempt under 802.4. Tax credits are assets, but we treat them as cash equivalents. K Walsh concurs.
HSR Informal Interpretations

1302004 Informal Interpretation

… 1302004 Informal Interpretation 1302004 Informal Interpretation From: (Redacted) Sent: Tuesday,February 12, 2013 … Michael; Walsh, Kathryn Subject: Item 8 -- ForeignPerson's Prior Acquisitions of Foreign Entities Mike and Kate - I …
Date
Rule
Form Item 8
This is correct.
Cases and Proceedings

IDEXX Laboratories, Inc., In the Matter of

… Matter of The largest U.S. supplier of diagnostic testing products used by small animal veterinarians, IDEXX … arrangements with a top distributor, resolving FTC charges that it was using the exclusive arrangements to … competition. IDEXX has agreed to a settlement order that prohibits concurrent exclusive distribution arrangements …

The largest U.S. supplier of diagnostic testing products used by small animal veterinarians, IDEXX Laboratories, Inc., agreed to drop its exclusive-dealing arrangements with a top distributor, resolving FTC charges that it was using the exclusive arrangements to stifle competition. IDEXX has agreed to a settlement order that prohibits concurrent exclusive distribution arrangements with the three national distributors of point-of-care (POC) diagnostic testing products. According to the FTC’s complaint, IDEXX has used its dominant market power to reduce competition by threatening to drop the distributors if they carried other companies’ products that compete with IDEXX products.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
1010023
Displaying 6141 - 6160 of 18372
Return to top